Tokyo Tape
Sign in
← Fukuda Denshi

Quarterly report · Q3

6960.TEDINET S100ST0Z
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥99.3bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥134.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥93.5bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥19.3bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥16.1bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥19.6bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥25.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥16.8bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥19.8bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥16.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥13.6bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥13.6bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥11.6bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥210.7bnat 2023-12-31Cons.Assets
Total assets¥206.9bnat 2023-03-31Cons.Assets
Total assets¥195.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥37.5bnat 2023-12-31Cons.Liabilities
Total liabilities¥43.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥173.2bnat 2023-12-31Cons.Net assets
Net assets / equity¥163.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥156.6bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥65.9bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥68.0bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥450.772023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥126.462023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥571.252022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥383.712022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥115.282022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio82.2%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio80.2%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥29.7bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥29.7bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥5.4bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥44.1bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥44.1bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥9.4bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥6.0bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.0bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥1.1bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2023-12-31¥19.5bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2023-12-31¥3.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥99.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥99.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥19.3bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥25.5bn
jpcrp040300-q3r_E02304-000Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥40.5bn
jpcrp040300-q3r_E02304-000Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.9bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥7.5bn
jpcrp040300-q3r_E02304-000Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.2bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.0bn
jpcrp040300-q3r_E02304-000Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2022-12-31¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥16.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 365
ItemContextValueUnit
Provision for product warrantiesPrior1YearInstant111000000JPY
Provision for product warrantiesCurrentQuarterInstant109000000JPY
Provision for bonusesPrior1YearInstant3953000000JPY
Provision for bonusesCurrentQuarterInstant1568000000JPY
Other provision clPrior1YearInstant546000000JPY
Other provision clCurrentQuarterInstant409000000JPY
Other clPrior1YearInstant8170000000JPY
Other clCurrentQuarterInstant6793000000JPY
Current liabilitiesPrior1YearInstant37514000000JPY
Current liabilitiesCurrentQuarterInstant31216000000JPY
Net defined benefit liabilityPrior1YearInstant2671000000JPY
Net defined benefit liabilityCurrentQuarterInstant2720000000JPY
Other provision nclPrior1YearInstant767000000JPY
Other provision nclCurrentQuarterInstant756000000JPY
Other nclPrior1YearInstant2921000000JPY
Other nclCurrentQuarterInstant2810000000JPY
Noncurrent liabilitiesPrior1YearInstant6360000000JPY
Noncurrent liabilitiesCurrentQuarterInstant6287000000JPY
LiabilitiesPrior1YearInstant43875000000JPY
LiabilitiesCurrentQuarterInstant37504000000JPY
Capital stockPrior1YearInstant4621000000JPY
Capital stockCurrentQuarterInstant4621000000JPY
Capital surplusPrior1YearInstant21887000000JPY
Capital surplusCurrentQuarterInstant21887000000JPY
Retained earningsPrior1YearInstant154156000000JPY
Retained earningsCurrentQuarterInstant162302000000JPY
Treasury stockPrior1YearInstant-20398000000JPY
Treasury stockCurrentQuarterInstant-20389000000JPY
Shareholders equityPrior1YearInstant160266000000JPY
Shareholders equityCurrentQuarterInstant168421000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant2395000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant4256000000JPY
Foreign currency translation adjustmentPrior1YearInstant198000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant395000000JPY
Remeasurements of defined benefit plansPrior1YearInstant188000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant159000000JPY
Valuation and translation adjustmentsPrior1YearInstant2781000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant4811000000JPY
Net assetsPrior1YearInstant163047000000JPY
Net assetsCurrentQuarterInstant173232000000JPY
Liabilities and net assetsPrior1YearInstant206922000000JPY
Liabilities and net assetsCurrentQuarterInstant210737000000JPY
Net salesPrior1YTDDuration93481000000JPY
Net salesCurrentYTDDuration99258000000JPY
Cost of salesPrior1YTDDuration44436000000JPY
Cost of salesCurrentYTDDuration45332000000JPY
Gross profitPrior1YTDDuration49044000000JPY
Gross profitCurrentYTDDuration53926000000JPY
Selling general and administrative expensesPrior1YTDDuration32966000000JPY
Selling general and administrative expensesCurrentYTDDuration34639000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass